Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.9864
-0.1836 (-15.69%)
At close: Jan 30, 2026, 4:00 PM EST
0.9832
-0.0032 (-0.32%)
After-hours: Jan 30, 2026, 7:48 PM EST
Genenta Science Market Cap
Genenta Science has a market cap or net worth of $23.11 million as of January 30, 2026. Its market cap has decreased by -73.40% in one year.
Market Cap
23.11M
Enterprise Value
11.24M
1-Year Change
-73.40%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since the IPO on December 15, 2021, Genenta Science's market cap has decreased from $208.76M to $23.11M, a decrease of -88.93%. That is a compound annual growth rate of -41.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 23.11M | -33.80% |
| Dec 31, 2025 | 34.91M | -56.12% |
| Dec 31, 2024 | 79.56M | -11.77% |
| Dec 29, 2023 | 90.17M | -10.00% |
| Dec 30, 2022 | 100.19M | -49.56% |
| Dec 31, 2021 | 198.63M | -4.85% |
| Dec 15, 2021 | 208.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exicure | 25.94M |
| IGC Pharma | 25.87M |
| Daré Bioscience | 25.86M |
| CollPlant Biotechnologies | 24.15M |
| FibroBiologics | 22.07M |
| Vistagen Therapeutics | 22.05M |
| Intensity Therapeutics | 21.96M |
| Neuphoria Therapeutics | 21.62M |